According to a recent article in the Washington Post, the most recent data period (1993-2006) showed an increase in hospitalizations for bedsores of 80 percent. http://www.washingtonpost.com/wp-dyn/content/article/2008/12/04/AR2008120402159_pf.html This at a time when bedsores are never supposed to happen in the medical community, at least according to federal guidelines. Also known as pressure ulcers or decubitus ulcers, bedsores typically afflict people who are bed-ridden — so they are largely problems for the elderly, invalids and people who have suffered strokes or dementia.
Pressure ulcers were the primary diagnosis in about 45,000 hospital admissions in 2006, compared to 35,800 in 1993. They were a secondary diagnosis in 457,800 admissions in 2006, compared to 245,600 in 1993. That seems to indicate that there were over half a million hospital admissions in 2006 related to bedsores — some of which were developed AFTER admission.
Bedsore hospitalizations, according to the Post article, last longer and cost more than many other hospitalizations, with an average stay of 13 to 14 days and an average cost of about $16,755 to $20,430, compared to an average stay for all admissions of 5 days and $10,000.
One new treatment for difficult-to-heal sores and wounds that has received wide interest has been the revival of the ancient custom of applying honey to sores to help them heal. A known antimicrobial, honey is inhospitable to bacteria, which is why you don’t have to refrigerate it at home. Seattle’s KING television, channel 5, summed it up recently: http://www.king5.com/health/stories/NW_100708HEB_medihoney_LJ.ede1f910.html And more recently, this article appeared on Channel 7 television in Denver, based on work done at Georgetown University: http://www.thedenverchannel.com/health/18248354/detail.html.
The product referenced is MediHONEY(tm), the only honey topical made from manuka honey from New Zealand, and the longest-lasting honey topical for advanced wound treatment. And unlike antibiotics, honey has few, if any, side effects.
For information on MediHONEY, which is a product of Derma Sciences Inc* (EBB:DSCI), visit http://www.dermasciences.com.